ACC 2019: Impact of Microvascular Disease on Cardiorenal Outcomes in Type 2 Diabetes

Published: 11 Apr 2019

  • Views:

    Views Icon 90
  • Likes:

    Heart Icon 1
Average (ratings)
No ratings
Your rating

Prof Subodh Verma (University of Toronto, Toronto, CA) discusses the impact of microvascular disease on cardiorenal outcomes in type 2 diabetes - an analysis from the LEADER and SUSTAIN-6 Clinical Trials.

Filmed on site at ACC 2019 by Radcliffe Cardiology.



Videography: Josh Birch

Interviewer: Liam O'Neill

This video was supported by an unrestricted educational grant from Novo Nordisk